Literature DB >> 18393909

Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia.

Karni S Moshal1, Naira Metreveli, Iuliana Frank, Suresh C Tyagi.   

Abstract

Chronic volume/pressure overload-induced heart failure augments oxidative stress and activates matrix metalloproteinase which causes endocardial endothelial-myocyte (EM) uncoupling eventually leading to decline in myocardial systolic and diastolic function. The elevated levels of homocysteine (Hcy), hyperhomocysteinemia (HHcy), are associated with decline in cardiac performance. Hcy impairs the EM functions associated with the induction of ventricular hypertrophy leading to cardiac stiffness and diastolic heart failure. Hcy-induced neurological defects are mediated by the NMDA-R (N-methyl-D-aspartate (NMDA) receptor) activation. NMDA-R is expressed in the heart. However, the role of NMDA-R on cardiac function during HHcy is still in its infancy. The blockade of NMDA-R attenuates NMDA-agonist-induced increase in the heart rate. Hcy increases intracellular calcium and activates calpain and calpain-associated mitochondrial (mt) abnormalities have been identified in HHcy. Mitochondrial permeabilization and uncoupling in the pathological setting is fueled by redox stress and calcium mishandling. Recently the role of cyclophilin D, a component of the mitochondrial membrane permeability transition pore, has been identified in cardiac-ischemia. Mechanisms underlying the potentiation between NMDA-R activation and mitochondrial defects leading to cardiac dysfunction during HHcy remain to be elucidated. This review addresses the mitochondrial mechanism by which Hcy contributes to the decline in mechano-electrical function and arrhythmogenesis via agonizing NMDA-R. The putative role of mitochondrial MMP activation, protease stress and mitochondrial permeability transition in cardiac conduction during HHcy is discussed. The review suggests that Hcy increases calcium overload and oxidative stress in the mitochondria and amplifies the activation of mtMMP, causing the opening of mitochondrial permeability transition pore leading to mechano-electrical dysfunction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18393909     DOI: 10.2174/157016108783955301

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  17 in total

Review 1.  Resuscitation of a dead cardiomyocyte.

Authors:  George H Kunkel; Pankaj Chaturvedi; Suresh C Tyagi
Journal:  Heart Fail Rev       Date:  2015-11       Impact factor: 4.214

2.  Novel role of mitochondrial matrix metalloproteinase-2 in the development of diabetic retinopathy.

Authors:  Ghulam Mohammad; Renu A Kowluru
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-01       Impact factor: 4.799

Review 3.  Cardiac matrix: a clue for future therapy.

Authors:  Paras Kumar Mishra; Srikanth Givvimani; Vishalakshi Chavali; Suresh C Tyagi
Journal:  Biochim Biophys Acta       Date:  2013-09-17

Review 4.  Mitochondrial mitophagic mechanisms of myocardial matrix metabolism and remodelling.

Authors:  Thomas P Vacek; Jonathan C Vacek; Suresh C Tyagi
Journal:  Arch Physiol Biochem       Date:  2011-12-19       Impact factor: 4.076

5.  Selenium restores defective beta-adrenergic receptor response of thoracic aorta in diabetic rats.

Authors:  Esma N Zeydanli; Ayca Bilginoglu; Evrim Tanriverdi; Hakan Gurdal; Belma Turan
Journal:  Mol Cell Biochem       Date:  2009-12-18       Impact factor: 3.396

6.  Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia.

Authors:  Karni S Moshal; Srinivas M Tipparaju; Thomas P Vacek; Munish Kumar; Mahavir Singh; Iluiana E Frank; Phani K Patibandla; Neetu Tyagi; Jayesh Rai; Naira Metreveli; Walter E Rodriguez; Michael T Tseng; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

7.  Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1.

Authors:  Karni S Moshal; Munish Kumar; Neetu Tyagi; Paras K Mishra; Naira Metreveli; Walter E Rodriguez; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

Review 8.  The role of homocysteine in bone remodeling.

Authors:  Thomas P Vacek; Anuradha Kalani; Michael J Voor; Suresh C Tyagi; Neetu Tyagi
Journal:  Clin Chem Lab Med       Date:  2013-03-01       Impact factor: 3.694

9.  Trimetazidine demonstrated cardioprotective effects through mitochondrial pathway in a model of acute coronary ischemia.

Authors:  L Dehina; F Vaillant; A Tabib; B Bui-Xuan; Ph Chevalier; N Dizerens; C Bui-Xuan; J Descotes; V Blanc-Guillemaud; L Lerond; Q Timour
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-22       Impact factor: 3.000

10.  Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery.

Authors:  Munish Kumar; Neetu Tyagi; Karni S Moshal; Utpal Sen; Soumi Kundu; Paras K Mishra; Srikanth Givvimani; Suresh C Tyagi
Journal:  Neurochem Int       Date:  2008-08-03       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.